Novavax, Inc. (NVAX): Price and Financial Metrics
Novavax, Inc. (NVAX)
Today's Latest Price: $126.25 USD
2.91 (-2.25%)
Updated Dec 4 4:00pm
Add NVAX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
NVAX Stock Summary
- Price to trailing twelve month operating cash flow for NVAX is currently 128.25, higher than 96.51% of US stocks with positive operating cash flow.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 29.36 for Novavax Inc; that's greater than it is for 98.77% of US stocks.
- Revenue growth over the past 12 months for Novavax Inc comes in at 1,181.88%, a number that bests 99.33% of the US stocks we're tracking.
- Stocks that are quantitatively similar to NVAX, based on their financial statements, market capitalization, and price volatility, are DRNA, CTMX, NKTR, AGIO, and RARE.
- Visit NVAX's SEC page to see the company's official filings. To visit the company's web site, go to www.novavax.com.
NVAX Stock Price Chart Interactive Chart >
NVAX Price/Volume Stats
| Current price | $126.25 | 52-week high | $189.40 |
| Prev. close | $129.16 | 52-week low | $3.65 |
| Day low | $125.04 | Volume | 2,181,700 |
| Day high | $130.49 | Avg. volume | 7,504,021 |
| 50-day MA | $100.95 | Dividend yield | N/A |
| 200-day MA | $75.56 | Market Cap | 8.04B |
Novavax, Inc. (NVAX) Company Bio
Novavax, Inc. focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company was founded in 1987 and is based in Gaithersburg, Maryland.
Loading social stream, please wait...